Role of genes involved in the regulation of apoptosis in the pathogenesis of genital endometriosis. A literature review

Abstract

BACKGROUND: The high prevalence, the lack of reliable data on the etiology, as well as the complexity of diagnosis and treatment of genital endometriosis indicate the urgency of the problem.

AIM: The aim of this study was to analyze and summarize scientific publications devoted to the study of single-nucleotide polymorphisms involved in apoptosis and their association with endometriosis.

MATERIALS AND METHODS: Based on keyword searches for “gene,” “SNP,” “apoptosis,” and “endometriosis,” a selection of papers published in open sources (PubMed and Google Scholar) in the period from 2010 to 2020 was performed.

RESULTS AND CONCLUSIONS: An analysis of the main and auxiliary apoptotic pathways was performed, with the protein regulators and their genes detailed in accordance with the implementation of the programmed cell death cascade in genital endometriosis. The review identified the significance of a number of proteins (TNF-á, FADD, CASP3, CASP7, CASP10) in the pathogenesis of hyperproliferative diseases. However, many apoptotic regulators (BCL2, BIK, BMF, HRK, BAD, Survivin) in genital endometriosis were found to have been understudied, which makes future research in this direction promising.

Keywords

endometriosis / apoptosis / apoptosis regulator / gene / single-nucleotide polymorphism

References

[1] Selkov SA, Yarmolinskaya MI. Endometriosis as a pathology of regulatory mechanisms. Journal of obstetrics and women’s diseases. 2017;66(2). (In Russ.). DOI: 10.17816/JOWD6629-13

[2] Сельков С.А., Ярмолинская М.И. Эндометриоз как патология регуляторных механизмов//Журнал акушерства и женских болезней. 2017. Т. 66. № 2. C. 9–13. DOI: 10.17816/JOWD6629-13

[3] Miller JE, Ahn SH, Monsanto SP, et al. Implications of immune dysfunction on endometriosis associated infertility. Oncotarget. 2017;8(4):7138–7147. DOI: 10.18632/oncotarget.12577

[4] Miller J.E., Ahn S.H., Monsanto S.P. et al. Implications of immune dysfunction on endometriosis associated infertility//Oncotarget. 2017. Vol. 8. No. 4. P. 7138–7147. DOI: 10.18632/oncotarget.12577

[5] De Conto E, Matte U, Cunha-Filho JS. BMP-6 and SMAD4 gene expression is altered in cumulus cells from women with endometriosis-associated infertility. Acta Obstet Gynecol Scand. 2021;100(5):868–875. DOI: 10.1111/aogs.13931

[6] De Conto E., Matte U., Cunha-Filho J.S. BMP-6 and SMAD4 gene expression is altered in cumulus cells from women with endometriosis-associated infertility//Acta. Obstet. Gynecol. Scand. 2021. Vol. 100. No. 5. P. 868–875. DOI: 10.1111/aogs.13931

[7] Yarmolinskaya MI, Khobets VV. The role of oxytocin in the pathogenesis of endometriosis: various aspects of the problem. Journal of obstetrics and women’s diseases. 2019;68(3):89–98. (In Russ.). DOI: 10.17816/JOWD68389-98

[8] Ярмолинская М.И., Хобец В.В. Роль окситоцина в патогенезе эндометриоза: различные грани проблемы//Журнал акушерства и женских болезней. 2019. Т. 68. № 3. C. 89–98. DOI: 10.17816/JOWD68389-98

[9] Kim JH, Han E. Endometriosis and female pelvic pain. Semin Reprod Med. 2018;36(2):143–151. DOI: 10.1055/s-0038-1676103

[10] Kim J.H., Han E. Endometriosis and female pelvic pain//Semin. Reprod. Med. 2018. Vol. 36. No. 2. P. 143–151. DOI: 10.1055/s-0038-1676103

[11] Schenk M, Kröpfl JM, Hörmann-Kröpfl M, Weiss G. Endometriosis accelerates synchronization of early embryo cell divisions but does not change morphokinetic dynamics in endometriosis patients. PLoS One. 2019;14(8):e0220529. DOI: 10.1371/journal.pone.0220529

[12] Schenk M., Kröpfl J.M., Hörmann-Kröpfl M., Weiss G. Endometriosis accelerates synchronization of early embryo cell divisions but does not change morphokinetic dynamics in endometriosis patients//PLoS One. 2019. Vol. 14. No. 8. P. e0220529. DOI: 10.1371/journal.pone.0220529

[13] Zondervan KT, Becker CM, Koga K, et al. Endometriosis. Nat Rev Dis Primers. 2018;4(1):9. DOI: 10.1038/s41572-018-0008-5

[14] Zondervan K.T., Becker C.M., Koga K. et al. Endometriosis//Nat. Rev. Dis. Primers. 2018. Vol. 4. No. 1. P. 9. DOI: 10.1038/s41572-018-0008-5

[15] Wang Y, Nicholes K, Shih IM. The origin and pathogenesis of endometriosis. Annu Rev Pathol. 2020;15:71–95. DOI: 10.1146/annurev-pathmechdis-012419-032654

[16] Wang Y., Nicholes K., Shih I.M. The origin and pathogenesis of endometriosis//Annu. Rev. Pathol. 2020. Vol. 15. P. 71–95. DOI: 10.1146/annurev-pathmechdis-012419-032654

[17] Gebel HM, Braun DP, Tambur A, et al. Spontaneous apoptosis of endometrial tissue is impaired in women with endometriosis. Fertil Steril. 1998;69(6):1042–1047. DOI: 10.1016/s0015-0282(98)00073-9

[18] Gebel H.M., Braun D.P., Tambur A. et al. Spontaneous apoptosis of endometrial tissue is impaired in women with endometriosis//Fertil. Steril. 1998. Vol. 69. No. 6. P. 1042–1047. DOI: 10.1016/s0015-0282(98)00073-9

[19] Dmowski WP, Gebel H, Braun DP. Decreased apoptosis and sensitivity to macrophage mediated cytolysis of endometrial cells in endometriosis. Hum Reprod Update. 1998;4(5):696–701. DOI: 10.1093/humupd/4.5.696

[20] Dmowski W.P., Gebel H., Braun D.P. Decreased apoptosis and sensitivity to macrophage mediated cytolysis of endometrial cells in endometriosis//Hum. Reprod. Update. 1998. Vol. 4. No. 5. P. 696–701. DOI: 10.1093/humupd/4.5.696

[21] Ichim G, Tait SW. A fate worse than death: apoptosis as an oncogenic process. Nat Rev Cancer. 2016;16(8):539–548. DOI: 10.1038/nrc.2016.58

[22] Ichim G., Tait S.W. A fate worse than death: apoptosis as an oncogenic process//Nat. Rev. Cancer. 2016. Vol. 16. No. 8. P. 539–548. DOI: 10.1038/nrc.2016.58

[23] Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol. 2008;9(3):231–241. DOI: 10.1038/nrm2312

[24] Taylor R.C., Cullen S.P., Martin S.J. Apoptosis: controlled demolition at the cellular level//Nat. Rev. Mol. Cell. Biol. 2008. Vol. 9. No. 3. P. 231–241. DOI: 10.1038/nrm2312

[25] Horiuchi T, Mitoma H, Harashima S, et al. Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents. Rheumatology (Oxford). 2010;49(7):1215–1228. DOI: 10.1093/rheumatology/keq031

[26] Horiuchi T., Mitoma H., Harashima S. et al. Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents//Rheumatology (Oxford). 2010. Vol. 49. No. 7. P. 1215–1228. DOI: 10.1093/rheumatology/keq031

[27] Haider S, Knöfler M. Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium. Placenta. 2009;30(2):111–123. DOI: 10.1016/j.placenta.2008.10.012

[28] Haider S., Knöfler M. Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium//Placenta. 2009. Vol. 30. No. 2. P. 111–123. DOI: 10.1016/j.placenta.2008.10.012

[29] Jarmolinskaja MI. Genital’nyj jendometrioz: vlijanie gormonal’nyh, immunologicheskih i geneticheskih faktorov na razvitie, osobennosti techenija i vybor terapii [dissertation]. St. Petersburg; 2009. (In Russ.). [cited 2021 Feb 18]. Available from: https://www.dissercat.com/content/genitalnyi-endometrioz-vliyanie-gormonalnykh-immunologicheskikh-i-geneticheskikh-faktorov-na

[30] Ярмолинская М.И. Генитальный эндометриоз: влияние гормональных, иммунологических и генетических факторов на развитие, особенности течения и выбор терапии: дис. … д-ра мед. наук. Санкт-Петербург, 2009.

[31] Abutorabi R, Baradaran A, Sadat Mostafavi F, et al. Evaluation of tumor necrosis factor alpha polymorphism frequencies in endometriosis. Int J Fertil Steril. 2015;9(3):329–337. DOI: 10.22074/ijfs.2015.4548

[32] Abutorabi R., Baradaran A., Sadat Mostafavi F. et al. Evaluation of tumor necrosis factor alpha polymorphism frequencies in endometriosis//Int. J. Fertil. Steril. 2015. Vol. 9. No. 3. P. 329–337. DOI: 10.22074/ijfs.2015.4548

[33] Medikare V, Ali A, Ananthapur V, et al. Susceptibility risk alleles of -238G/A, -308G/A and -1031T/C promoter polymorphisms of TNF- gene to uterine leiomyomas. Recent Adv DNA Gene Seq. 2015;9(1):65–71. DOI: 10.2174/2352092210999151214155858

[34] Medikare V., Ali A., Ananthapur V. et al. Susceptibility risk alleles of -238G/A, -308G/A and -1031T/C promoter polymorphisms of TNF- gene to uterine leiomyomas//Recent Adv. DNA Gene Seq. 2015. Vol. 9. No. 1. P. 65–71. DOI: 10.2174/2352092210999151214155858

[35] Escobar-Morreale HF, Calvo RM, Sancho J, San Millán JL. TNF-alpha and hyperandrogenism: a clinical, biochemical, and molecular genetic study. J Clin Endocrinol Metab. 2001;86(8):3761–3767. DOI: 10.1210/jcem.86.8.7770

[36] Escobar-Morreale H.F., Calvo R.M., Sancho J., San Millán J.L. TNF-alpha and hyperandrogenism: a clinical, biochemical, and molecular genetic study//J. Clin. Endocrinol. Metab. 2001. Vol. 86. No. 8. P. 3761–3767. DOI: 10.1210/jcem.86.8.7770

[37] Yun JH, Choi JW, Lee KJ, et al. The promoter -1031(T/C) polymorphism in tumor necrosis factor-alpha associated with polycystic ovary syndrome. Reprod Biol Endocrinol. 2011;9:131. DOI: 10.1186/1477-7827-9-131

[38] Yun J.H., Choi J.W., Lee K.J. et al. The promoter -1031(T/C) polymorphism in tumor necrosis factor-alpha associated with polycystic ovary syndrome//Reprod. Biol. Endocrinol. 2011. Vol. 9. P. 131. DOI: 10.1186/1477-7827-9-131

[39] Babaabasi B, Ahani A, Sadeghi F, et al. The association between TNF-alpha gene polymorphisms and endometriosis in an Iranian population. Int J Fertil Steril. 2019;13(1):6–11. DOI: 10.22074/ijfs.2019.5542

[40] Babaabasi B., Ahani A., Sadeghi F. et al. The association between TNF-alpha gene polymorphisms and endometriosis in an Iranian population//Int. J. Fertil. Steril. 2019. Vol. 13. No. 1. P. 6–11. DOI: 10.22074/ijfs.2019.5542

[41] Zhao ZZ, Nyholt DR, Le L, et al. Genetic variation in tumour necrosis factor and lymphotoxin is not associated with endometriosis in an Australian sample. Hum Reprod. 2007;22(9):2389–2397. DOI: 10.1093/humrep/dem182

[42] Zhao Z.Z., Nyholt D.R., Le L. et al. Genetic variation in tumour necrosis factor and lymphotoxin is not associated with endometriosis in an Australian sample//Hum. Reprod. 2007. Vol. 22. No. 9. P. 2389–2397. DOI: 10.1093/humrep/dem182

[43] Saliminejad K, Memariani T, Ardekani AM, et al. Association study of the TNF- -1031T/C and VEGF +450G/C polymorphisms with susceptibility to endometriosis. Gynecol Endocrinol. 2013;29(11):974–977. DOI: 10.3109/09513590.2013.824956

[44] Saliminejad K., Memariani T., Ardekani A.M. et al. Association study of the TNF- -1031T/C and VEGF +450G/C polymorphisms with susceptibility to endometriosis//Gynecol. Endocrinol. 2013. Vol. 29. No. 11. P. 974–977. DOI: 10.3109/09513590.2013.824956

[45] Drakou A, Mavrogianni D, Ntzeros K, et al. Association between tumor necrosis factor- gene-1031T/C promoter polymorphism and endometriosis in a European population. Horm Mol Biol Clin Investig. 2019;40(2):90–96. DOI: 10.1515/hmbci-2019-0033

[46] Drakou A., Mavrogianni D., Ntzeros K. et al. Association between tumor necrosis factor- gene -1031T/C promoter polymorphism and endometriosis in a European population//Horm. Mol. Biol. Clin. Investig. 2019. Vol. 40. No. 2. P. 90–96. DOI: 10.1515/hmbci-2019-0033

[47] Teramoto M, Kitawaki J, Koshiba H, et al. Genetic contribution of tumor necrosis factor (TNF)-alpha gene promoter (-1031, -863 and -857) and TNF receptor 2 gene polymorphisms in endometriosis susceptibility. Am J Reprod Immunol. 2004;51(5):352–357. DOI: 10.1111/j.1600-0897.2004.00168.x

[48] Teramoto M., Kitawaki J., Koshiba H. et al. Genetic contribution of tumor necrosis factor (TNF)-alpha gene promoter (-1031, -863 and -857) and TNF receptor 2 gene polymorphisms in endometriosis susceptibility//Am. J. Reprod. Immunol. 2004. Vol. 51. No. 5. P. 352–357. DOI: 10.1111/j.1600-0897.2004.00168.x

[49] Delsouc MB, Ghersa F, Ramírez D, et al. Endometriosis progression in tumor necrosis factor receptor p55-deficient mice: Impact on oxidative/nitrosative stress and metallomic profile. J Trace Elem Med Biol. 2019;52:157–165. DOI: 10.1016/j.jtemb.2018.12.013

[50] Delsouc M.B., Ghersa F., Ramírez D. et al. Endometriosis progression in tumor necrosis factor receptor p55-deficient mice: Impact on oxidative/nitrosative stress and metallomic profile//J. Trace Elem. Med. Biol. 2019. Vol. 52. P. 157–165. DOI: 10.1016/j.jtemb.2018.12.013

[51] Akhavan Sales Z, Tahoori MT, Sheikhha MH, et al. Identification of a FAS/FASL haplotype associated with endometriosis in Iranian patients. Gynecol Endocrinol. 2020;36(3):261–264. DOI: 10.1080/09513590.2019.1655729

[52] Akhavan Sales Z., Tahoori M.T., Sheikhha M.H. et al. Identification of a FAS/FASL haplotype associated with endometriosis in Iranian patients//Gynecol. Endocrinol. 2020. Vol. 36. No. 3. P. 261–264. DOI: 10.1080/09513590.2019.1655729

[53] Xu Y, He B, Li R, et al. Association of the polymorphisms in the Fas/FasL promoter regions with cancer susceptibility: a systematic review and meta-analysis of 52 studies. PLoS One. 2014;9(3):e90090. DOI: 10.1371/journal.pone.0090090

[54] Xu Y., He B., Li R. et al. Association of the polymorphisms in the Fas/FasL promoter regions with cancer susceptibility: a systematic review and meta-analysis of 52 studies//PLoS One. 2014. Vol. 9. No. 3. P. e90090. DOI: 10.1371/journal.pone.0090090

[55] Mohammadzadeh A, Pourfathollah AA, Tahoori MT, et al. Evaluation of apoptosis-related gene Fas (CD95) and FasL (CD178) polymorphisms in Iranian rheumatoid arthritis patients. Rheumatol Int. 2012;32(9):2833–2836. DOI: 10.1007/s00296-011-2065-x

[56] Mohammadzadeh A., Pourfathollah A.A., Tahoori M.T. et al. Evaluation of apoptosis-related gene Fas (CD95) and FasL (CD178) polymorphisms in Iranian rheumatoid arthritis patients//Rheumatol. Int. 2012. Vol. 32. No. 9. P. 2833–2836. DOI: 10.1007/s00296-011-2065-x

[57] Wang T, Lian Y. The relationship between Fas and Fas ligand gene polymorphism and preeclampsia risk. Biosci Rep. 2019;39(2):BSR20181901. DOI: 10.1042/BSR20181901

[58] Wang T., Lian Y. The relationship between Fas and Fas ligand gene polymorphism and preeclampsia risk//Biosci. Rep. 2019. Vol. 39. No. 2. P. BSR20181901. DOI: 10.1042/BSR20181901

[59] Karakus S, Sancakdar E, Akkar O, et al. Elevated serum CD95/FAS and HIF-1 levels, but not Tie-2 levels, may be biomarkers in patients with severe endometriosis: a preliminary report. J Minim Invasive Gynecol. 2016;23(4):573–577. DOI: 10.1016/j.jmig.2016.01.025

[60] Karakus S., Sancakdar E., Akkar O. et al. Elevated serum CD95/FAS and HIF-1 levels, but not Tie-2 levels, may be biomarkers in patients with severe endometriosis: a preliminary report//J. Minim. Invasive. Gynecol. 2016. Vol. 23. No. 4. P. 573–577. DOI: 10.1016/j.jmig.2016.01.025

[61] Pissetti CW, Tanaka SCSV, Hortolani ACC, Marqui ABT. Gene polymorphisms in FAS (Rs3740286 and Rs4064) are involved in endometriosis development in brazilian women, but not those in CASP8 (rs13416436 and rs2037815). Rev Bras Ginecol Obstet. 2018;40(8):450–457. DOI: 10.1055/s-0038-1667183

[62] Pissetti C.W., Tanaka S.C.S.V., Hortolani A.C.C., Marqui A.B.T. Gene polymorphisms in FAS (Rs3740286 and Rs4064) are involved in endometriosis development in brazilian women, but not those in CASP8 (rs13416436 and rs2037815)//Rev. Bras. Ginecol. Obstet. 2018. Vol. 40. No. 8. P. 450–457. DOI: 10.1055/s-0038-1667183

[63] Kim H, Ku SY, Suh CS, Kim SH, et al. Association between endometriosis and polymorphisms in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptor and osteoprotegerin genes and their serum levels. Arch Gynecol Obstet. 2012;286(1):147–153. DOI: 10.1007/s00404-012-2263-0

[64] Kim H., Ku S.Y., Suh C.S. et al. Association between endometriosis and polymorphisms in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptor and osteoprotegerin genes and their serum levels//Arch. Gynecol. Obstet. 2012. Vol. 286. No. 1. P. 147–153. DOI: 10.1007/s00404-012-2263-0

[65] Wang SH, Cao Z, Wolf JM, et al. Death ligand tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis. Endocrinology. 2005;146(11):4721–4726. DOI: 10.1210/en.2005-0627

[66] Wang S.H., Cao Z., Wolf J.M. et al. Death ligand tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis//Endocrinology. 2005. Vol. 146. No. 11. P. 4721–4726. DOI: 10.1210/en.2005-0627

[67] Othman ER, Hornung D, Hussein M, et al. Soluble tumor necrosis factor-alpha receptors in the serum of endometriosis patients. Eur J Obstet Gynecol Reprod Biol. 2016;200:1–5. DOI: 10.1016/j.ejogrb.2016.02.025.

[68] Othman E.R., Hornung D., Hussein M. et al. Soluble tumor necrosis factor-alpha receptors in the serum of endometriosis patients//Eur. J. Obstet. Gynecol. Reprod. Biol. 2016. Vol. 200. P. 1–5. DOI: 10.1016/j.ejogrb.2016.02.025

[69] Tummers B, Green DR. Caspase-8: regulating life and death. Immunol Rev. 2017;277(1):76–89. DOI: 10.1111/imr.12541

[70] Tummers B., Green D.R. Caspase-8: regulating life and death//Immunol. Rev. 2017. Vol. 277. No. 1. P. 76–89. DOI: 10.1111/imr.12541

[71] Di Nisio V, Rossi G, Di Luigi G, et al. Increased levels of proapoptotic markers in normal ovarian cortex surrounding small endometriotic cysts. Reprod Biol. 2019;19(3):225–229. DOI: 10.1016/j.repbio.2019.08.002

[72] Di Nisio V., Rossi G., Di Luigi G. et al. Increased levels of proapoptotic markers in normal ovarian cortex surrounding small endometriotic cysts//Reprod. Biol. 2019. Vol. 19. No. 3. P. 225–229. DOI: 10.1016/j.repbio.2019.08.002

[73] Sundqvist J, Xu H, Vodolazkaia A, et al. Replication of endometriosis-associated single-nucleotide polymorphisms from genome-wide association studies in a Caucasian population. Hum Reprod. 2013;28(3):835–839. DOI: 10.1093/humrep/des457

[74] Sundqvist J., Xu H., Vodolazkaia A. et al. Replication of endometriosis-associated single-nucleotide polymorphisms from genome-wide association studies in a Caucasian population//Hum. Reprod. 2013. Vol. 28. No. 3. P. 835–839. DOI: 10.1093/humrep/des457

[75] Oh JE, Kim MS, Ahn CH, et al. Mutational analysis of CASP10 gene in colon, breast, lung and hepatocellular carcinomas. Pathology. 2010;42(1):73–76. DOI: 10.3109/00313020903434371

[76] Oh J.E., Kim M.S., Ahn C.H. et al. Mutational analysis of CASP10 gene in colon, breast, lung and hepatocellular carcinomas//Pathology. 2010. Vol. 42. No. 1. P. 73–76. DOI: 10.3109/00313020903434371

[77] Yan S, Li YZ, Zhu JW, et al. Role of CASP-10 gene polymorphisms in cancer susceptibility: a HuGE review and meta-analysis. Genet Mol Res. 2012;11(4):3998–4007. DOI: 10.4238/2012.November.26.1

[78] Yan S., Li Y.Z., Zhu J.W. et al. Role of CASP-10 gene polymorphisms in cancer susceptibility: a HuGE review and meta-analysis//Genet. Mol. Res. 2012. Vol. 11. No. 4. P. 3998–4007. DOI: 10.4238/2012.November.26.1

[79] Brentnall M, Rodriguez-Menocal L, De Guevara RL, et al. Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell Biol. 2013;14:32. DOI: 10.1186/1471-2121-14-32

[80] Brentnall M., Rodriguez-Menocal L., De Guevara R.L. et al. Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis//BMC Cell Biol. 2013. Vol. 14. P. 32. DOI: 10.1186/1471-2121-14-32

[81] Wei WD, Ruan F, Tu FX, et al. Expression of suppressor of cytokine signaling-3 and caspase-3 in endometriosis and their correlation. Zhonghua Bing Li Xue Za Zhi. 2013;42(8):515–518.

[82] Wei W.D., Ruan F., Tu F.X. et al. Expression of suppressor of cytokine signaling-3 and caspase-3 in endometriosis and their correlation//Zhonghua Bing Li Xue Za Zhi. 2013. Vol. 42. No. 8. P. 515–518.

[83] Kaya C, Alay I, Guraslan H, et al. The role of serum caspase 3 levels in prediction of endometriosis severity. Gynecol Obstet Invest. 2018;83(6):576–585. DOI: 10.1159/000489494

[84] Kaya C., Alay I., Guraslan H. et al. The role of serum caspase 3 levels in prediction of endometriosis severity//Gynecol. Obstet. Invest. 2018. Vol. 83. No. 6. P. 576–585. DOI: 10.1159/000489494

[85] Xu HL, Xu WH, Cai Q, et al. Polymorphisms and haplotypes in the caspase-3, caspase-7, and caspase-8 genes and risk for endometrial cancer: a population-based, case-control study in a Chinese population. Cancer Epidemiol Biomarkers Prev. 2009;18(7):2114–2122. DOI: 10.1158/1055-9965.EPI-09-0152

[86] Xu H.L., Xu W.H., Cai Q. et al. Polymorphisms and haplotypes in the caspase-3, caspase-7, and caspase-8 genes and risk for endometrial cancer: a population-based, case-control study in a Chinese population//Cancer Epidemiol. Biomarkers Prev. 2009. Vol. 18. No. 7. P. 2114–2122. DOI: 10.1158/1055-9965.EPI-09-0152

[87] Chon J, Hong JH, Kim J, et al. Association between BH3 interacting domain death agonist (BID) gene polymorphism and ossification of the posterior longitudinal ligament in Korean population. Mol Biol Rep. 2014;41(2):895–899. DOI: 10.1007/s11033-013-2933-4

[88] Chon J., Hong J.H., Kim J. et al. Association between BH3 interacting domain death agonist (BID) gene polymorphism and ossification of the posterior longitudinal ligament in Korean population//Mol. Biol. Rep. 2014. Vol. 41. No. 2. P. 895–899. DOI: 10.1007/s11033-013-2933-4

[89] Csordás G, Weaver D, Hajnóczky G. Endoplasmic reticulum-mitochondrial contactology: structure and signaling functions. Trends Cell Biol. 2018;28(7):523–540. DOI: 10.1016/j.tcb.2018.02.009

[90] Csordás G., Weaver D., Hajnóczky G. Endoplasmic reticulum-mitochondrial contactology: structure and signaling functions//Trends Cell Biol. 2018. Vol. 28. No. 7. P. 523–540. DOI: 10.1016/j.tcb.2018.02.009

[91] Zong WX, Lindsten T, Ross AJ, et al. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev. 2001;15(12):1481–1486. DOI: 10.1101/gad.897601

[92] Zong W.X., Lindsten T., Ross A.J. et al. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak//Genes Dev. 2001. Vol. 15. No. 12. P. 1481–1486. DOI: 10.1101/gad.897601

[93] Chene G, Ouellet V, Rahimi K, et al. The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis. Int J Gynaecol Obstet. 2015;130(1):27–30. DOI: 10.1016/j.ijgo.2015.02.021

[94] Chene G., Ouellet V., Rahimi K. et al. The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis//Int. J. Gynaecol. Obstet. 2015. Vol. 130. No. 1. P. 27–30. DOI: 10.1016/j.ijgo.2015.02.021

[95] Grishkina AA, Chistyakova GN, Remizova II, et al. Expression of inducer (NOXA) and inhibitor (BCL-2) of apoptosis in the thin endometrium of infertile women. Sovremennye problemy nauki i obrazovanija. 2020;(2):141–141. (In Russ.). DOI: 10.17513/spno.29686

[96] Гришкина А.А., Чистякова Г.Н., Ремизова И.И. и др. Экспрессия индуктора (NOXA) и ингибитора (BCL-2) апоптоза в эндометрии при гипоплазии и бесплодии//Современные проблемы науки и образования. 2020. № 2. С. 141–141. DOI: 10.17513/spno.29686

[97] Korkmaz D, Bastu E, Dural O, et al. Apoptosis through regulation of Bcl-2, Bax and Mcl-1 expressions in endometriotic cyst lesions and the endometrium of women with moderate to severe endometriosis. J Obstet Gynaecol. 2013;33(7):725–728. DOI: 10.3109/01443615.2013.824416

[98] Korkmaz D., Bastu E., Dural O. et al. Apoptosis through regulation of Bcl-2, Bax and Mcl-1 expressions in endometriotic cyst lesions and the endometrium of women with moderate to severe endometriosis//J. Obstet. Gynaecol. 2013. Vol. 33. No. 7. P. 725–728. DOI: 10.3109/01443615.2013.824416

[99] Delbandi AA, Mahmoudi M, Shervin A, et al. Evaluation of apoptosis and angiogenesis in ectopic and eutopic stromal cells of patients with endometriosis compared to non-endometriotic controls. BMC Womens Health. 2020;20(1):3. DOI: 10.1186/s12905-019-0865-4

[100] Delbandi A.A., Mahmoudi M., Shervin A. et al. Evaluation of apoptosis and angiogenesis in ectopic and eutopic stromal cells of patients with endometriosis compared to non-endometriotic controls//BMC Womens Health. 2020. Vol. 20. No. 1. P. 3. DOI: 10.1186/s12905-019-0865-4

[101] Depalo R, Cavallini A, Lorusso F, et al. Apoptosis in normal ovaries of women with and without endometriosis. Reprod Biomed Online. 2009;19(6):808–815. DOI: 10.1016/j.rbmo.2009.09.024

[102] Depalo R., Cavallini A., Lorusso F. et al. Apoptosis in normal ovaries of women with and without endometriosis//Reprod. Biomed. Online. 2009. Vol. 19. No. 6. P. 808–815. DOI: 10.1016/j.rbmo.2009.09.024

[103] Kholoussi NM, El-Nabi SE, Esmaiel NN, et al. Evaluation of Bax and Bak gene mutations and expression in breast cancer. Biomed Res Int. 2014;2014:249372. DOI: 10.1155/2014/249372

[104] Kholoussi N.M., El-Nabi S.E., Esmaiel N.N. et al. Evaluation of Bax and Bak gene mutations and expression in breast cancer//Biomed. Res. Int. 2014. Vol. 2014. P. 249372. DOI: 10.1155/2014/249372

[105] Panzan MQ, Mattar R, Maganhin CC, et al. Evaluation of FAS and caspase-3 in the endometrial tissue of patients with idiopathic infertility and recurrent pregnancy loss. Eur J Obstet Gynecol Reprod Biol. 2013;167(1):47–52. DOI: 10.1016/j.ejogrb.2012.10.021

[106] Panzan M.Q., Mattar R., Maganhin C.C. et al. Evaluation of FAS and caspase-3 in the endometrial tissue of patients with idiopathic infertility and recurrent pregnancy loss//Eur. J. Obstet. Gynecol. Reprod. Biol. 2013. Vol. 167. No. 1. P. 47–52. DOI: 10.1016/j.ejogrb.2012.10.021

[107] Delbandi AA, Mahmoudi M, Shervin A, et al. Evaluation of apoptosis and angiogenesis in ectopic and eutopic stromal cells of patients with endometriosis compared to non-endometriotic controls. BMC Womens Health. 2020;20(1):3. DOI: 10.1186/s12905-019-0865-4

[108] Delbandi A.A., Mahmoudi M., Shervin A. et al. Evaluation of apoptosis and angiogenesis in ectopic and eutopic stromal cells of patients with endometriosis compared to non-endometriotic controls//BMC Womens Health. 2020. Vol. 20. No. 1. P. 3. DOI: 10.1186/s12905-019-0865-4

[109] Huniadi CA, Pop OL, Antal TA, Stamatian F. The effects of ulipristal on Bax/Bcl-2, cytochrome c, Ki-67 and cyclooxygenase-2 expression in a rat model with surgically induced endometriosis. Eur J Obstet Gynecol Reprod Biol. 2013;169(2):360–365. DOI: 10.1016/j.ejogrb.2013.03.022

[110] Huniadi C.A., Pop O.L., Antal T.A., Stamatian F. The effects of ulipristal on Bax/Bcl-2, cytochrome c, Ki-67 and cyclooxygenase-2 expression in a rat model with surgically induced endometriosis//Eur. J. Obstet. Gynecol. Reprod. Biol. 2013. Vol. 169. No. 2. P. 360–365. DOI: 10.1016/j.ejogrb.2013.03.022

[111] Leavy O. Reproductive immunology: Evading immunosurveillance in endometriosis. Nat Rev Immunol. 2015;15(12):729. DOI: 10.1038/nri3942

[112] Leavy O. Reproductive immunology: Evading immunosurveillance in endometriosis//Nat. Rev. Immunol. 2015. Vol. 15. No. 12. P. 729. DOI: 10.1038/nri3942

[113] Zhang ZY, Xuan Y, Jin XY, et al. CASP-9 gene functional polymorphisms and cancer risk: a large-scale association study plus meta-analysis. Genet Mol Res. 2013;12(3):3070–3078. DOI: 10.4238/2013.February.28.22

[114] Zhang Z.Y., Xuan Y., Jin X.Y. et al. CASP-9 gene functional polymorphisms and cancer risk: a large-scale association study plus meta-analysis//Genet. Mol. Res. 2013. Vol. 12. No. 3. P. 3070–3078. DOI: 10.4238/2013.February.28.22

[115] Xu XR, Wang X, Zhang H, et al. The clinical significance of the combined detection of serum Smac, HE4 and CA125 in endometriosis-associated ovarian cancer. Cancer Biomark. 2018;21(2):471–477. DOI: 10.3233/CBM-170720

[116] Xu X.R., Wang X., Zhang H. et al. The clinical significance of the combined detection of serum Smac, HE4 and CA125 in endometriosis-associated ovarian cancer//Cancer Biomark. 2018. Vol. 21. No. 2. P. 471–477. DOI: 10.3233/CBM-170720

[117] Lalaoui N, Vaux DL. Recent advances in understanding inhibitor of apoptosis proteins. F1000Res. 2018;7:F1000 Faculty Rev-1889. DOI: 10.12688/f1000research.16439.1

[118] Lalaoui N., Vaux D.L. Recent advances in understanding inhibitor of apoptosis proteins//F1000Res. 2018. Vol. 7. P. F1000 Faculty Rev-1889. DOI: 10.12688/f1000research.16439.1

[119] Fulda S, Vucic D. Targeting IAP proteins for therapeutic intervention in cancer. Nat Rev Drug Discov. 2012;11(2):109–124. Corrected and republished from: Nat Rev Drug Discov. 2012;11(4):331. DOI: 10.1038/nrd3627

[120] Fulda S., Vucic D. Targeting IAP proteins for therapeutic intervention in cancer//Nat. Rev. Drug Discov. 2012. Vol. 11. No. 2. P. 109–124. Corrected and republished from: Nat. Rev. Drug Discov. 2012. Vol. 11. No. 4. P. 331. DOI: 10.1038/nrd3627

[121] Chang CM, Wang ML, Lu KH, et al. Integrating the dysregulated inflammasome-based molecular functionome in the malignant transformation of endometriosis-associated ovarian carcinoma. Oncotarget. 2017;9(3):3704–3726. DOI: 10.18632/oncotarget.23364

[122] Chang C.M., Wang M.L., Lu K.H. et al. Integrating the dysregulated inflammasome-based molecular functionome in the malignant transformation of endometriosis-associated ovarian carcinoma//Oncotarget. 2017. Vol. 9. No. 3. P. 3704–3726. DOI: 10.18632/oncotarget.23364

[123] Liu XY, Wang HJ, Xu P, et al. Expressions of livin and PTEN in cancerous tissues of ovary endometriosis. Sichuan Da Xue Xue Bao Yi Xue Ban. 2016;47(4):512–515.

[124] Liu X.Y., Wang H.J., Xu P. et al. Expressions of livin and PTEN in cancerous tissues of ovary endometriosis//Sichuan Da Xue Xue Bao Yi Xue Ban. 2016. Vol. 47. No. 4. P. 512–515.

[125] Uegaki T, Taniguchi F, Nakamura K, et al. Inhibitor of apoptosis proteins (IAPs) may be effective therapeutic targets for treating endometriosis. Hum Reprod. 2015;30(1):149–158. DOI: 10.1093/humrep/deu288

[126] Uegaki T., Taniguchi F., Nakamura K. et al. Inhibitor of apoptosis proteins (IAPs) may be effective therapeutic targets for treating endometriosis//Hum. Reprod. 2015. Vol. 30. No. 1. P. 149–158. DOI: 10.1093/humrep/deu288

[127] Di Nisio V, Rossi G, Di Luigi G, et al. Increased levels of proapoptotic markers in normal ovarian cortex surrounding small endometriotic cysts. Reprod Biol. 2019;19(3):225–229. DOI: 10.1016/j.repbio.2019.08.002

[128] Di Nisio V., Rossi G., Di Luigi G. et al. Increased levels of proapoptotic markers in normal ovarian cortex surrounding small endometriotic cysts//Reprod. Biol. 2019. Vol. 19. No. 3. P. 225–229. DOI: 10.1016/j.repbio.2019.08.002

[129] Dorien O, Waelkens E, Vanhie A, et al. The use of antibody arrays in the discovery of new plasma biomarkers for endometriosis. Reprod Sci. 2020;27(2):751–762. DOI: 10.1007/s43032-019-00081-w

[130] Dorien O., Waelkens E., Vanhie A. et al. The use of antibody arrays in the discovery of new plasma biomarkers for endometriosis//Reprod. Sci. 2020. Vol. 27. No. 2. P. 751–762. DOI: 10.1007/s43032-019-00081-w

[131] Filipchiuk C, Laganà AS, Beteli R, et al. BIRC5/Survivin expression as a non-invasive biomarker of endometriosis. Diagnostics (Basel). 2020;10(8):533. DOI: 10.3390/diagnostics10080533

[132] Filipchiuk C., Laganà A.S., Beteli R. et al. BIRC5/Survivin expression as a non-invasive biomarker of endometriosis//Diagnostics (Basel). 2020. Vol. 10. No. 8. P. 533. DOI: 10.3390/diagnostics10080533

[133] Acimovic M, Vidakovic S, Milic N, et al. Survivin and VEGF as novel biomarkers in diagnosis of endometriosis. J Med Biochem. 2016;35(1):63–68. DOI: 10.1515/jomb-2015-0005

[134] Acimovic M., Vidakovic S., Milic N. et al. Survivin and VEGF as novel biomarkers in diagnosis of endometriosis//J. Med. Biochem. 2016. Vol. 35. No. 1. P. 63–68. DOI: 10.1515/jomb-2015-0005

[135] Lamp M, Saare M, Kadastik Ü, et al. Survivin promoter polymorphisms and autoantibodies in endometriosis. J Reprod Immunol. 2012;96(1–2):95–100. DOI: 10.1016/j.jri.2012.10.001

[136] Lamp M., Saare M., Kadastik Ü. et al. Survivin promoter polymorphisms and autoantibodies in endometriosis//J. Reprod. Immunol. 2012. Vol. 96. No. 1–2. P. 95–100. DOI: 10.1016/j.jri.2012.10.001

[137] Vigneswara V, Ahmed Z. The role of Caspase-2 in regulating cell fate. Cells. 2020;9(5):1259. DOI: 10.3390/cells9051259

[138] Vigneswara V., Ahmed Z. The role of Caspase-2 in regulating cell fate//Cells. 2020. Vol. 9. No. 5. P. 1259. DOI: 10.3390/cells9051259

[139] Sladky VC, Villunger A. Uncovering the PIDDosome and caspase-2 as regulators of organogenesis and cellular differentiation. Cell Death Differ. 2020;27(7):2037–2047. DOI: 10.1038/s41418-020-0556-6

[140] Sladky V.C., Villunger A. Uncovering the PIDDosome and caspase-2 as regulators of organogenesis and cellular differentiation//Cell Death Differ. 2020. Vol. 27. No. 7. P. 2037–2047. DOI: 10.1038/s41418-020-0556-6

[141] Haupt S, Berger M, Goldberg Z, Haupt Y. Apoptosis – the p53 network. J Cell Sci. 2003;116(Pt 20):4077–4085. DOI: 10.1242/jcs.00739

[142] Haupt S., Berger M., Goldberg Z., Haupt Y. Apoptosis – the p53 network//J. Cell Sci. 2003. Vol. 116. (Pt. 20). P. 4077–4085. DOI: 10.1242/jcs.00739

[143] Duan R, Wang Y, Lin A, et al. Expression of nm23-H1, p53, and integrin 1 in endometriosis and their clinical significance. Int J Clin Exp Pathol. 2020;13(5):1024–1029.

[144] Duan R., Wang Y., Lin A. et al. Expression of nm23-H1, p53, and integrin 1 in endometriosis and their clinical significance//Int. J. Clin. Exp. Pathol. 2020. Vol. 13. No. 5. P. 1024–1029.

[145] Camargo-Kosugi CM, D’Amora P, Kleine JP, et al. TP53 gene polymorphisms at codons 11, 72, and 248 and association with endometriosis in a Brazilian population. Genet Mol Res. 2014;13(3):6503–6511. DOI: 10.4238/2014.August.26.1

[146] Camargo-Kosugi C.M., D’Amora P., Kleine J.P. et al. TP53 gene polymorphisms at codons 11, 72, and 248 and association with endometriosis in a Brazilian population//Genet. Mol. Res. 2014. Vol. 13. No. 3. P. 6503–6511. DOI: 10.4238/2014.August.26.1

[147] Yan Y, Wu R, Li S, He J. Meta-analysis of association between the TP53 Arg72Pro polymorphism and risk of endometriosis based on case-control studies. Eur J Obstet Gynecol Reprod Biol. 2015;189:1–7. DOI: 10.1016/j.ejogrb.2015.03.015

[148] Yan Y., Wu R., Li S., He J. Meta-analysis of association between the TP53 Arg72Pro polymorphism and risk of endometriosis based on case-control studies//Eur. J. Obstet. Gynecol. Reprod. Biol. 2015. Vol. 189. P. 1–7. DOI: 10.1016/j.ejogrb.2015.03.015

[149] Govatati S, Chakravarty B, Deenadayal M, et al. p53 and risk of endometriosis in Indian women. Genet Test Mol Biomarkers. 2012;16(8):865–873. DOI: 10.1089/gtmb.2011.0295

[150] Govatati S., Chakravarty B., Deenadayal M. et al. p53 and risk of endometriosis in Indian women//Genet. Test Mol. Biomarkers. 2012. Vol. 16. No. 8. P. 865–873. DOI: 10.1089/gtmb.2011.0295

[151] Gallegos-Arreola MP, Valencia-Rodríguez LE, Puebla-Pérez AM, et al. The TP53 16-bp duplication polymorphism is enriched in endometriosis patients. Gynecol Obstet Invest. 2012;73(2):118–123. DOI: 10.1159/000330702

[152] Gallegos-Arreola M.P., Valencia-Rodríguez L.E., Puebla-Pérez A.M. et al. The TP53 16-bp duplication polymorphism is enriched in endometriosis patients//Gynecol. Obstet. Invest. 2012. Vol. 73. No. 2. P. 118–123. DOI: 10.1159/000330702

[153] Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol. 2003;4(7):552–565. DOI: 10.1038/nrm1150

[154] Orrenius S., Zhivotovsky B., Nicotera P. Regulation of cell death: the calcium-apoptosis link//Nat. Rev. Mol. Cell Biol. 2003. Vol. 4. No. 7. P. 552–565. DOI: 10.1038/nrm1150

[155] Lieberman J. Granzyme A activates another way to die. Immunol Rev. 2010;235(1):93–104. DOI: 10.1111/j.0105-2896.2010.00902.x

[156] Lieberman J. Granzyme A activates another way to die//Immunol. Rev. 2010. Vol. 235. No. 1. P. 93–104. DOI: 10.1111/j.0105-2896.2010.00902.x

[157] Islimye Taskin M, Guney G, Adali E, et al. Granzyme B levels and granzyme B polymorphisms in peripheral blood of patients with endometriosis: a preliminary study. J Obstet Gynaecol. 2021;41(1):94–99. DOI: 10.1080/01443615.2019.1697220

[158] Islimye Taskin M., Guney G., Adali E. et al. Granzyme B levels and granzyme B polymorphisms in peripheral blood of patients with endometriosis: a preliminary study//J. Obstet. Gynaecol. 2021. Vol. 41. No. 1. P. 94–99. DOI: 10.1080/01443615.2019.1697220

[159] Ichim G, Tait SW. A fate worse than death: apoptosis as an oncogenic process. Nat Rev Cancer. 2016;16(8):539–548. DOI: 10.1038/nrc.2016.58

[160] Ichim G., Tait S.W. A fate worse than death: apoptosis as an oncogenic process//Nat. Rev. Cancer. 2016. Vol. 16. No. 8. P. 539–548. DOI: 10.1038/nrc.2016.58

RIGHTS & PERMISSIONS

Eсо-Vector